BCSH/BSBMT/UK clinical virology network guideline: Diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation

British Journal of Haematology

Volumn 173, Issue 3, 2016, Pages 380-393

  Dignan, Fiona L ^a   Clark, Andrew ^b   Aitken, Celia ^c   Gilleece, Maria ^d   Jayakar, Vishal ^e   Krishnamurthy, Pramila ^f   Pagliuca, Antonio ^g   Potter, Michael N ^h   Shaw, Bronwen ^h   Skinner, Roderick ⁱ   Turner, Andrew ^a   Wynn, Robert F ^j   Coyle, Peter ^k  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^e KINGSTON HOSPITAL   (United Kingdom)

^f ADDENBROOKE S HOSPITAL   (United Kingdom)

^g KING S COLLEGE HOSPITAL   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ Infectious Diseases Allergy   (United Kingdom)

^j ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^k ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

more..

Author keywords

Influenza; Metapneumovirus; Parainfluenza; Respiratory syncytial virus; Stem cell transplant

Indexed keywords

BETA1A INTERFERON; FAVIPIRAVIR; IMMUNOGLOBULIN; INFLUENZA VACCINE; OSELTAMIVIR; PALIVIZUMAB; PLECONARIL; RIBAVIRIN; RIMANTADINE; SIALIDASE INHIBITOR; VAPENDAVIR; ZANAMIVIR;

ANAPHYLAXIS; ANEMIA; ARTICLE; ASTHMA; BRONCHOSPASM; CLAUSTROPHOBIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DISEASE COURSE; DRUG DOSE INCREASE; GRAFT VERSUS HOST REACTION; HAND WASHING; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMAN; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; HUMAN PARAINFLUENZA VIRUS 2; HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYPERBILIRUBINEMIA; INCUBATION TIME; INFECTION CONTROL; INFLUENZA; LENGTH OF STAY; LEUKOPENIA; LIVER DYSFUNCTION; LOADING DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; LUNG INSUFFICIENCY; LYMPHOCYTE COUNT; MEDICAL PRACTICE; METAPNEUMOVIRUS INFECTION; MORTALITY; MYELOABLATIVE CONDITIONING; NAUSEA; NAUSEA AND VOMITING; NEUTROPHIL COUNT; NOMENCLATURE; NOSE SMEAR; NUCLEIC ACID AMPLIFICATION; OCULAR PRURITUS; ORTHOMYXOVIRIDAE; PARAINFLUENZA VIRUS INFECTION; PARAMYXOVIRIDAE; PATIENT CARE; PICORNAVIRIDAE; PNEUMOCYSTIS JIROVECI; PNEUMONIA; POLYMERASE CHAIN REACTION; POST EXPOSURE PROPHYLAXIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RASH; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; RISK FACTOR; SEASONAL VARIATION; THORAX RADIOGRAPHY; THROAT CULTURE; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION; ADOLESCENT; ADULT; ADVERSE EFFECTS; CHILD; COMPLICATION; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOLOGY; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; STANDARDS; STEM CELL TRANSPLANTATION; VIROLOGY; VIRUS DISEASES; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOLOGY; HUMANS; MALE; MIDDLE AGED; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; STEM CELL TRANSPLANTATION; UNITED KINGDOM; VIRUS DISEASES; YOUNG ADULT;

EID: 84963770967     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14027     Document Type: Article

References (87)

1. Alymova, I.V., Portner, A., Takimoto, T., Boyd, K.L., Babu, Y.S. & McCullers, J.A. (2005) The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae. Antimicrobial Agents Chemotherapy, 49, 398-405.
2. Anaissie, E.J., Mahfouz, T.H., Aslan, T., Pouli, A., Desikan, R., Fassas, A. & Barlogie, B. (2004) The natural history of respiratory syncytial virus infection in cancer and transplant patients: implications for management. Blood, 103, 1611-1617.
3. Barik, S. & Lu, P. (2015) Therapy of respiratory viral infections with intranasal siRNAs. Methods in Molecular Biology, 1218, 251-262.
4. Berglund, A., Willén, L., Grödeberg, L., Skattum, L., Hagberg, H. & Pauksens, K. (2014) The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab. Acta Oncologica, 53, 1212-1220.
5. Blaschke, A.J., Allison, M.A., Meyers, L., Rogatcheva, M., Heyrend, C., Mallin, B., Carter, M., Lafleur, B., Barney, T., Poritz, M.A., Daly, J.A. & Byington, C.L. (2011) Non-invasive sample collection for respiratory virus testing by multiplex PCR. Journal of Clinical Virology, 52, 210-214.
6. Boeckh, M., Berrey, M.M., Bowden, R.A., Crawford, S.W., Balsley, J. & Corey, L. (2001) Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. Journal of Infectious Diseases., 184, 350-354.
7. Boeckh, M., Englund, J., Li, Y., Miller, C., Cross, A., Fernandez, H., Kuypers, J., Kim, H., Gnann, J. & Whitley, R.; NIAID Collaborative Antiviral Study Group. (2007) Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upperrespiratory tract infection in hematopoietic cell transplant recipients. Clinical Infectious Diseases, 44, 245-249.
8. Bonney, D., Razali, H., Turner, A. & Will, A. (2009) Successful treatment of human metapneumovirus pneumonia using combination therapy with intravenous ribavirin and immune globulin. British Journal of Haematology, 145, 667-669.
9. Bosch, A.A., Biesbroek, G., Trzcinski, K., Sanders, E.A. & Bogaert, D. (2013) Viral and bacterial interactions in the upper respiratory tract. PLoS Pathogens., 9, e1003057.
10. Campbell, A.P., Guthrie, K.A., Englund, J.A., Farney, R.M., Minerich, E.L., Kuypers, J., Corey, L. & Boeckh, M. (2015) Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant. Clinical Infectious Diseases, 61, 192-202. Apr 5. pii: civ272 DOI: 10.1093/cid/civ272
11. Casey, J., Morris, K., Narayana, M., Nakagaki, M. & Kennedy, G.A. (2013) Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation, 48, 1558-1561.
12. Casper, C., Englund, J. & Boeckh, M. (2010) How I treat influenza in patients with hematologic malignancies. Blood, 115, 1331-1342.
13. Chakrabarti, S., Collingham, K.E., Holder, K., Oyaide, S., Pillay, D. & Milligan, D.W. (2000) Parainfluenza virus type 3 infections in hematopoietic stem cell transplant recipients: response to ribavirin therapy. Clinical Infectious Diseases, 31, 1516-1518.
14. Champlin, R.E. & Whimbey, E. (2001) Community respiratory virus infections in bone marrow transplant recipients: the M.D. Anderson Cancer Center experience. Biology of Blood and Marrow Transplantation, 7, 8S-10S.
15. Chemaly, R.F., Torres, H.A., Aguilera, E.A., Mattiuzzi, G., Cabanillas, M., Kantarjian, H., Gonzalez, V., Safdar, A. & Raad, I.I. (2007) Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clinical Infectious Diseases, 44, 964-967.
16. Chemaly, R.F., Torres, H.A., Munsell, M.F., Shah, D.P., Rathod, D.B., Bodey, G.P., Hosing, C., Saifan, C., Raad, I.I. & Champlin, R.E. (2012a) An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. Journal of Infectious Diseases, 206, 1367-1371.
17. Chemaly, R.F., Hanmod, S.S., Rathod, D.B., Ghantoji, S.S., Jiang, Y., Doshi, A., Vigil, K., Adachi, J.A., Khoury, A.M., Tarrand, J., Hosing, C. & Champlin, R. (2012b) The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood, 119, 2738-2745.
18. Chen, Y.B., Driscoll, J.P., McAfee, S.L., Spitzer, T.R., Rosenberg, E.S., Sanders, R., Moss, R.B., Fang, F. & Marty, F.M. (2011) Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation. Clinical Infectious Diseases, 53, e77-e80.
19. Choi, S.M., Boudreault, A.A., Xie, H., Englund, J.A., Corey, L. & Boeckh, M. (2011) Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood, 117, 5050-5056.
20. Chretien, J.P., George, D., Shaman, J., Chitale, R.A. & McKenzie, F.E. (2014) Influenza forecasting in human populations: a scoping review. PLoS ONE, 9, e94130.
21. Corti, D., Bianchi, S., Vanzetta, F., Minola, A., Perez, L., Agatic, G., Guarino, B., Silacci, C., Marcandalli, J., Marsland, B.J., Piralla, A., Percivalle, E., Sallusto, F., Baldanti, F. & Lanzavecchia, A. (2013) Cross-neutralization of four paramyxoviruses by a human monoclonal antibody. Nature, 501, 439-443.
22. Deffrasnes, C., Hamelin, M.E., Prince, G.A. & Boivin, G. (2008) Identification and evaluation of a highly effective fusion inhibitor for human metapneumovirus. Antimicrobial Agents Chemotherapy, 52, 279-287.
23. Del, P.P., Abarca, K., Concha, I. & Cerda, J. (2014) Concordance of nasal swabs and nasopharyngeal swabs in the detection of respiratory viruses by direct immunofluorescence. Revista Chilena de Infectologia, 31, 160-164.
24. Dignan, F., Alvares, C., Riley, U., Ethell, M., Cunningham, D., Treleaven, J., Ashley, S., Bendig, J., Morgan, G. & Potter, M. (2006) Parainfluenza type 3 infection post stem cell transplant: high prevalence but low mortality. Journal of Hospital Infection., 63, 452-458.
25. Dobson, J., Whitley, R.J., Pocock, S. & Monto, A.S. (2000) Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. The Lancet, 385, 1729-1737.
26. Egli, A., Bucher, C., Dumoulin, A., Stern, M., Buser, A., Bubendorf, L., Gregor, M., Servida, P., Sommer, G., Bremerich, J., Gratwohl, A., Khanna, N., Widmer, A.F., Battegay, M., Tamm, M., Hirsch, H.H. & Halter, J.P. (2012) Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection, 40, 677-684.
27. de Fontbrune, F.S., Robin, M., Porcher, R., Scieux, C., de Latour, R.P., Ferry, C., Rocha, V., Boudjedir, K., Devergie, A., Bergeron, A., Gluckman, E., Azoulay, E., Lapalu, J., Socié, G. & Ribaud, P. (2007) Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases, 45, 1019-1024.
28. Fraaij, P.L., van der Vries, E., Beersma, M.F., Riezebos-Brilman, A., Niesters, H.G., van der Eijk, A.A., de Jong, M.D., Reis Miranda, D., Horrevorts, A.M., Ridwan, B.U., Wolfhagen, M.J., Houmes, R.J., van Dissel, J.T., Fouchier, R.A., Kroes, A.C., Koopmans, M.P., Osterhaus, A.D. & Boucher, C.A. (2011) Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection. Journal of Infectious Diseases., 2011, 777-782.
29. Fry, A.M., Curns, A.T., Harbour, K., Hutwagner, L., Holman, R.C. & Anderson, L.J. (2006) Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clinical Infectious Diseases, 43, 1016-1022.
30. Furuta, Y., Takahashi, K., Shiraki, K., Sakamoto, K., Smee, D.F., Barnard, D.L., Gowen, B.B., Julander, J.G. & Morrey, J.D. (2009) T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections. Antiviral Research, 82, 95-102.
31. Haas, L.E., Thijsen, S.F., van Elden, L. & Heemstra, K.A. (2013) Human metapneumovirus in adults. Viruses, 5, 87-110.
32. Hamelin, M.E., Gagnon, C., Prince, G.A., Kiener, P., Suzich, J., Ulbrandt, N. & Boivin, G. (2010) Prophylactic and therapeutic benefits of a monoclonal antibody against the fusion protein of human metapneumovirus in a mouse model. Antiviral Research, 88, 31-37.
33. Hayden, F.G., Herrington, D.T., Coats, T.L., Kim, K., Cooper, E.C., Villano, S.A., Liu, S., Hudson, S., Pevear, D.C., Collett, M. & McKinlay, M.; Pleconaril Respiratory Infection Study Group. (2003) Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials. Clinical Infectious Diseases, 36, 1523-1532.
34. Henrickson, K.J. (2003) Parainfluenza viruses. Clinical Microbiology Reviews, 16, 242-264.
35. Hirsch, H.H., Martino, R., Ward, K.N., Boeckh, M., Einsele, H. & Ljungman, P. (2013) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clinical Infectious Diseases, 56, 258-266.
36. Ison, M.G. (2007) Respiratory viral infections in transplant recipients. Antiviral Therapy, 12(4 Pt B), 627-638.
37. Ison, M.G. (2011) Epidemiology, prevention, and management of influenza in patients with hematologic malignancy. Infectious Disorders - Drug Targets, 11, 34-39.
38. Ison, M.G., Hayden, F.G., Kaiser, L., Corey, L. & Boeckh, M. (2003) Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia. Clinical Infectious Diseases, 36, 1139-1143.
39. Jacobs, S.E., Soave, R., Shore, T.B., Satlin, M.J., Schuetz, A.N., Magro, C., Jenkins, S.G. & Walsh, T.J. (2013a) Human rhinovirus infections of the lower respiratory tract in hematopoietic stem cell transplant recipients. Transplant Infectious Disease, 15, 474-486.
40. Jacobs, S.E., Lamson, D.M., St George, K. & Walsh, T.J. (2013b) Human rhinoviruses. Clinical Microbiology Reviews., 26, 135-162.
41. Jain, B., Singh, A.K., Dangi, T., Agarwal, A., Verma, A.K., Dwivedi, M., Singh, K.P. & Jain, A. (2014) High prevalence of human metapneumovirus subtype B in cases presenting as severe acute respiratory illness: an experience at tertiary care hospital. The Clinical Respiratory Journal, 8, 225-233.
42. Johnstone, J., Majumdar, S.R., Fox, J.D. & Marrie, T.J. (2008) Viral infection in adults hospitalized with community-acquired pneumonia: prevalence, pathogens, and presentation. Chest, 134, 1141-1148.
43. Joos, L., Chhajed, P.N., Wallner, J., Battegay, M., Steiger, J., Gratwohl, A. & Tamm, M. (2007) Pulmonary infections diagnosed by BAL: a 12-year experience in 1066 immunocompromised patients. Respiratory Medicine, 101, 93-97.
44. Khanna, N., Widmer, A.F., Decker, M., Steffen, I., Halter, J., Heim, D., Weisser, M., Gratwohl, A., Fluckiger, U. & Hirsch, H.H. (2008) Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clinical Infectious Diseases, 46, 402-412.
45. Kim, Y.J., Guthrie, K.A., Waghmare, A., Walsh, E.E., Falsey, A.R., Kuypers, J., Cent, A., Englund, J.A. & Boeckh, M. (2014) Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease. Journal of Infectious Diseases, 209, 1195-1204.
46. Kitanovski, L., Kopriva, S., Pokorn, M., Dolničar, M.B., Rajić, V., Stefanović, M. & Jazbec, J. (2013) Treatment of severe human metapneumovirus (hMPV) pneumonia in an immunocompromised child with oral ribavirin and IVIG. Journal of Pediatric Hematology/oncology, 35, e311-e313.
47. Lessler, J., Reich, N.G., Brookmeyer, R., Perl, T.M., Nelson, K.E. & Cummings, D.A. (2009) Incubation periods of acute respiratory viral infections: a systematic review. The Lancet Infectious Disease, 9, 291-300.
48. Ljungman, P., Ward, K.N., Crooks, B.N.A., Parker, A., Martino, R., Shaw, P.J., Brinch, L., Brune, M., De La Camara, R., Dekker, A., Pauksen, K., Russell, N., Schwarer, A.P. & Cordonnier, C. (2001) Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation, 28, 479-484.
49. Ljungman, P., de la Camara, R., Perez-Bercoff, L., Abecasis, M, Campuzano, J.B.N., Cannata-Ortiz, M.J., Cordonnier, C., Einsele, H., Gonzalez-Vicent, M., Espigado, I., Halter, J., Martino, R., Mohty, B., Sucak, G., Ullmann, A.J., Vázquez, L., Ward, K.N. & Engelhard, D.; for the Infectious Diseases Working Party of the European Group, for Blood and Marrow Transplantation (EBMT), and the Infectious Complications Subcommittee of the Spanish Group of Haematopoietic Stem-cell Transplantation (GETH). (2011) Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica, 96, 1231-1235.
50. Marcelin, J.R., Wilson, J.W. & Razonable, R.R. (2014) Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients. Transplant Infectious Disease, 16, 242-250.
51. Martino, R., Porras, R.P., Rabella, N., Williams, J.V., Rámila, E., Margall, N., Labeaga, R., Crowe, J.E. Jr, Coll, P. & Sierra, J. (2005) Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biology of Blood and Marrow Transplantation, 11, 781-796.
52. Mohty, B., Thomas, Y., Vukicevic, M., Nagy, M., Levrat, E., Bernimoulin, M., Kaiser, L., Roosnek, E., Passweg, J. & Chalandon, Y. (2012) Clinical features and outcome of 2009-influenza A (H1N1) after allogeneic hematopoietic SCT. Bone Marrow Transplantation, 47, 236-242.
53. Moore, M.L., Stokes, K.L. & Hartert, T.V. (2013) The impact of viral genotype on pathogenesis and disease severity: respiratory syncytial virus and humanrhinoviruses. Current Opinion in Immunology., 25, 761-768.
54. NICE. (2008) Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza. NICE technology appraisal guidance [TA158], Guidance section. © National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ta158/chapter/1-Guidance (last accessed 15 November 2015).
55. Nichols, W.G., Corey, L., Gooley, T., Davis, C. & Boeckh, M. (2001) Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome. Blood, 98, 573-578.
56. Nichols, W.G., Guthrie, K.A., Corey, L. & Boeckh, M. (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clinical Infectious Disease, 39, 1300-1306.
57. Ohrmalm, L., Wong, M., Rotzen-Ostlund, M., Norbeck, O., Broliden, K. & Tolfvenstam, T. (2010) Flocked nasal swab versus nasopharyngeal aspirate for detection of respiratory tract viruses in immunocompromised adults: a matched comparative study. BMC Infectious Diseases, 10, 340.
58. Ottolini, M.G., Curtis, S.R., Mathews, A., Ottolini, S.R. & Prince, G.A. (2002) Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model. Bone Marrow Transplantation, 29, 117-120.
59. Peck, A.J., Corey, L. & Boeckh, M. (2004) Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantation. Clinical Infectious Diseases, 39, 673-680.
60. Pevear, D.C., Hayden, F.G., Demenczuk, T.M., Barone, L.R., McKinlay, M.A. & Collett, M.S. (2005) Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses. Antimicrobial Agents and Chemotherapy, 49, 4492-4499.
61. Pica, N. & Bouvier, N.M. (2012) Environmental factors affecting the transmission of respiratory viruses. Current Opinion in Virology., 2, 90-95.
62. Public Health England. (2013) Influenza. In: Immunisation Against Infectious Disease (Eds: Salisbury, D., Ramsay, M. Chapter 19. © Crown Copyright. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/456568/2904394_Green_Book_Chapter_19_v10_0.pdf (last accessed 1 November 2015).
63. Renaud, C. & Campbell, A.P. (2011) Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Current Opinion in Infectious Diseases, 24, 333-343.
64. Renaud, C., Xie, H., Seo, S., Kuypers, J., Cent, A., Corey, L., Leisenring, W., Boeckh, M. & Englund, J.A. (2013) Mortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients. Biology of Blood and Marrow Transplantation, 19, 1220-1226.
65. Rubin, L.G., Levin, M.J., Ljungman, P., Davies, E.G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H. & Kang, I. (2014) Infectious diseases society of America. Clinical Infectious Disease, 58, 309-318.
66. Safdar, A. (2008) Immune modulatory activity of ribavirin for serious human metapneumovirus disease: early i.v. therapy may improve outcomes in immunosuppressed SCT recipients. Bone Marrow Transplantation, 41, 707-708.
67. Schiffer, J.T., Kirby, K., Sandmaier, B., Storb, R., Corey, L. & Boeckh, M. (2009) Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation. Haematologica, 94, 1101-1108.
68. Schomacker, H., Schaap-Nutt, A., Collins, P.L. & Schmidt, A.C. (2012) Pathogenesis of acute respiratory illness caused by human parainfluenza viruses. Current Opinion in Virology., 2, 294-299.
69. Shachor-Meyouhas, Y., Ben-Barak, A. & Kassis, I. (2012) Treatment with oral ribavirin and IVIG of severe human metapneumovirus pneumonia (HMPV) in immune compromised child. Pediatric Blood & Cancer, 57, 350-351. Erratum in: Pediatr Blood Cancer., 58, 319.
70. Shah, J.N. & Chemaly, R.F. (2011) Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood, 117, 2755-2763.
71. Shah, D.P., Ghantoji, S.S., Shah, J.N., El Taoum, K.K., Jiang, Y., Popat, U., Hosing, C., Rondon, G., Tarrand, J.J., Champlin, R.E. & Chemaly, R.F. (2013) Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. Journal of Antimicrobial Chemotherapy, 68, 1872-1880.
72. Shah, D.P., Ghantoji, S.S., Ariza-Heredia, E.J., Shah, J.N., El Taoum, K.K., Shah, P.K., Nesher, L., Hosing, C., Rondon, G., Champlin, R.E. & Chemaly, R.F. (2014) Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infections. Blood, 123, 3263-3268.
73. Shahda, S., Carlos, W.G., Kiel, P.J., Khan, B.A. & Hage, C.A. (2011) The human metapneumovirus: a case series and review of the literature. Transplant Infectious Diseases, 13, 324-328.
74. Shima, T., Yoshimoto, G., Nonami, A., Yoshida, S., Kamezaki, K., Iwasaki, H., Takenaka, K., Miyamoto, T., Harada, N., Teshima, T., Akashi, K. & Nagafuji, K. (2008) Successful treatment of parainfluenza virus 3 pneumonia with oral ribavirin and methylprednisolone in a bone marrow transplant recipient. International Journal of Hematology, 88, 336-340.
75. Sleeman, K., Mishin, V.P., Deyde, V.M., Furuta, Y., Klimov, A.I. & Gubareva, L.V. (2010) In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrobial Agents and Chemotherapy, 54, 2517-2524.
76. Sparrelid, E., Ljungman, P., Ekelöf-Andström, E., Aschan, J., Ringdén, O., Winiarski, J., Wåhlin, B. & Andersson, J. (1997) Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections. Bone Marrow Transplantation, 19, 905-908.
77. Stankova, J., Carret, A.S., Moore, D., McCusker, C., Mitchell, D., Davis, M., Mazer, B. & Jabado, N. (2007) Long-term therapy with aerosolized ribavirin for parainfluenza 3 virus respiratory tract infection in an infant with severe combined immunodeficiency. Pediatric Transplantation, 11, 209-213.
78. The IMpact-RSV Study Group. (1998) Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics, 1998, 531-537.
79. Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J.R., Young, J.A. & Boeckh, M.J.; Center for International Blood and Marrow Research, National Marrow Donor program, European Blood and MarrowTransplant Group, American Society of Blood and Marrow Transplantation, Canadian Blood and Marrow Transplant Group; Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, Association of Medical Microbiology and Infectious Disease Canada, Centers for Disease Control and Prevention. (2009) Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biology of Blood and Marrow Transplantation, 15, 1143-1238.
80. Tunsjo, H.S., Berg, A.S., Inchley, C.S., Roberg, I.K. & Leegaard, T.M. (2015) Comparison of nasopharyngeal aspirate with flocked swab for PCR-detection of respiratory viruses in children. APMIS, 123, 473-477. 2015 Apr 23 doi: 10.1111/apm.12375
81. Ulbrandt, N.D., Ji, H., Patel, N.K., Barnes, A.S., Wilson, S., Kiener, P.A., Suzich, J. & McCarthy, M.P. (2008) Identification of antibody neutralization epitopes on the fusion protein of humanmetapneumovirus. Journal of General Virology, 89, 3113-3118.
82. Walsh, E.E., Falsey, A.R. & Hennessey, P.A. (1999) Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. American Journal of Respiratory and Critical Care Medicine, 160, 791-795.
83. Walsh, E.E., Peterson, D.R. & Falsey, A.R. (2008) Human metapneumovirus infections in adults: another piece of the puzzle. Archives of Internal Medicine, 168, 2489-2496.
84. Whimbey, E., Englund, J.A. & Couch, R.B. (1997) Community respiratory virus infections in immunocompromised patients with cancer. American Journal of Medicine, 102, 10-18; discussion 25-6.
85. Widmer, K., Zhu, Y., Williams, J.V., Griffin, M.R., Edwards, K.M. & Talbot, H.K. (2012) Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. Journal of Infectious Diseases, 206, 56-62.
86. Williamson, J.C. & Pegram, P.S. (2000) Respiratory distress associated with zanamivir. New England Journal of Medicine, 342, 661-662.
87. Wyde, P.R., Chetty, S.N., Jewell, A.M., Boivin, G. & Piedra, P.A. (2003) Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Research, 60, 51-59.